Connect with us

Hi, what are you looking for?

Investing

Safety Shot launching clinical trial to measure effect of its drink on blood alcohol levels

Safety Shot Inc.’s stock SHOT was down 5% in in premarket trading on Friday after the company said it started a clinical trial to measure the effects of its Safety Shot drink on blood and breath alcohol. The product is designed as a nutraceutical functional beverage that accelerates the body’s breakdown of alcohol while aiding in recovery and rehydration, the company said. The study includes a double-blinded placebo-controlled test in 36 participants to measure the amount of alcohol in the blood and breath, together with indices of alcohol effects. The company said it plans to launch business-to-business sales of Safety…

Master your money.

Subscribe to MarketWatch.

Get this article and all of MarketWatch.

Access from any device. Anywhere. Anytime.

Subscribe Now

Log In

Read the full article here

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

News

This article was written by Follow Hi, my names Tyler! While I am currently a student at University of South Carolina well on my...

News

This article was written by Follow Buyside analyst covering global stocks on Seeking Alpha since 2018. I’ve been investing personally and professionally across major...